Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on New York Business Digest.
Press releases published on July 8, 2025

Endeavour Silver Produces 1,483,736 Oz Silver and 7,755 Oz Gold (2.5 Million Silver Equivalent Oz) in Q2 2025
VANCOUVER, British Columbia, July 08, 2025 (GLOBE NEWSWIRE) -- Endeavour Silver Corp. (“Endeavour” or the “Company”) (NYSE: EXK; TSX: EDR) reports second quarter 2025 production of 1,483,736 silver ounces (oz), 7,755 gold oz, and in combination with base …

CANADA CARBON ANNONCE L'OBTENTION DES PERMIS NÉCESSAIRES POUR SA TROISIÈME CAMPAGNE DE FORAGE SUR LA PROPRIÉTÉ ASBURY GRAPHITE
Montréal, Québec, Canada, 08 juill. 2025 (GLOBE NEWSWIRE) -- Canada Carbon Inc. (TSX-V : CCB), (« Canada Carbon » ou « la Société ») annonce qu'elle a obtenu tous les permis nécessaires du gouvernement du Québec pour commencer sa troisième campagne de …

CANADA CARBON ANNOUNCES RECEIPT OF NECESSARY PERMITS FOR ITS THIRD DRILLING CAMPAIGN ON ASBURY GRAPHITE PROPERTY
Montreal, Quebec, Canada, July 08, 2025 (GLOBE NEWSWIRE) -- Canada Carbon Inc. (TSX-V: CCB), (“Canada Carbon” or “the Company”) announces that it has obtained all necessary permits from the Quebec government to commence with its third drilling campaign in …

CODI FINAL DEADLINE ALERT: Hagens Berman Alerts Compass Diversified (CODI) Investors to Today’s Lead Plaintiff Deadline in Securities Class Action
SAN FRANCISCO, July 08, 2025 (GLOBE NEWSWIRE) -- After hours on June 25, 2025, Connecticut-based private equity firm Compass Diversified (NYSE: CODI) filed a report with the SEC warning investors not to rely on previously issued financial statements for …

Willis launches $200m facility to tackle global geopolitical uncertainty for cargo owners
LONDON, July 08, 2025 (GLOBE NEWSWIRE) -- Willis, a WTW business (NASDAQ: WTW), has launched ‘Undercover’, a new $200 million facility, combining coverage for a range of geopolitical exposures faced by cargo owners worldwide. Developed by Willis in a joint …

H2O America Significantly Expands Texas Footprint with Texas Subsidiary’s Acquisition of Quadvest
More Than Doubles H2O America’s Connections in Texas and Increases Exposure to High Growth Houston Region Drives Scale, Increases Financial and Operational Diversification, and Enhances Value and Reliability for Customers, Communities, and All Stakeholders …

Calian Reinforces Support for Canadian Armed Forces with $250M Contract Amendment
OTTAWA, Ontario, July 08, 2025 (GLOBE NEWSWIRE) -- Calian Group Ltd. (TSX: CGY), a mission-critical solutions company focused on defence, space, healthcare and other strategic critical infrastructure sectors, today announced a $250 million amendment to its …

Diagonal Therapeutics Appoints John Lee, M.D., Ph.D., as Chief Medical Officer
Biotech veteran will lead clinical development of Diagonal’s clustering antibody pipeline, including DIAG723 for hereditary hemorrhagic telangiectasia (HHT) and pulmonary arterial hypertension (PAH) WATERTOWN, Mass., July 08, 2025 (GLOBE NEWSWIRE) -- …

Mercury Receives Two New Common Processing Architecture Production Awards
ANDOVER, Mass., July 08, 2025 (GLOBE NEWSWIRE) -- Mercury Systems, Inc. (NASDAQ: MRCY, www.mrcy.com), a technology company that delivers mission-critical processing to the edge, today announced it received two new production awards in June totaling $36.9 …

CervoMed Announces Late-Breaking Presentations at Alzheimer’s Association® International Congress 2025
BOSTON, July 08, 2025 (GLOBE NEWSWIRE) -- CervoMed Inc. (NASDAQ: CRVO), a clinical stage company focused on developing treatments for age-related neurologic disorders, today announced it will deliver Developing Topics (late-breaking) virtual and in-person …

PyroGenesis Improves Fumed Silica Quality, Purity, and Consistency Across Multiple Production Cycles
MONTREAL, July 08, 2025 (GLOBE NEWSWIRE) -- PyroGenesis Inc. (“PyroGenesis”) (http://pyrogenesis.com) (TSX: PYR) (OTCQX: PYRGF) (FRA: 8PY1), a high-tech company that designs, develops, manufactures and commercializes all-electric plasma processes and …

Agios Appoints Dr. Jay Backstrom to Board of Directors
CAMBRIDGE, Mass., July 08, 2025 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a leader in cellular metabolism and pyruvate kinase (PK) activation pioneering therapies for rare diseases, today announced the appointment of Jay Backstrom, M. …

OTC Markets Group Welcomes Vaxart, Inc. to OTCQX
NEW YORK, July 08, 2025 (GLOBE NEWSWIRE) -- OTC Markets Group Inc. (OTCQX: OTCM), operator of regulated markets for trading 12,000 U.S. and international securities, today announced Vaxart, Inc. (OTCQX: VXRT), a clinical-stage biotechnology company, has …

Churchill Reports High-Grade Zinc Results on Polymetallic Veins at the Black Raven Property, Central Newfoundland
TORONTO, July 08, 2025 (GLOBE NEWSWIRE) -- Churchill Resources Inc. (“Churchill” or the “Company”) (TSXV: CRI) is pleased to announce the final due-diligence sample results on its Black Raven property with three over-limit zinc assays of 5.25%, 11.03% and …

Microbix & Bulgaria’s NCIPD Execute Supply Agreement
MISSISSAUGA, Ontario and SOFIA, Bulgaria, July 08, 2025 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, and the National Center for Infectious and Parasitic Diseases …

ProKidney Reports Statistically and Clinically Significant Topline Results for the Phase 2 REGEN-007 Trial Evaluating Rilparencel in Patients with Chronic Kidney Disease and Diabetes
Full results from REGEN-007 are being held and will be submitted to the American Society of Nephrology 2025 Kidney Week as a late-breaking clinical trial In Group 1 (n=24), kidney function stabilized in patients randomized to receive two rilparencel …

ROM: Golden Age Blasts Past 500,000 Pre-Registrations - Join the Buddy Boost Lottery for a Shot at Massive Crypto Prizes
Singapore, July 08, 2025 (GLOBE NEWSWIRE) -- Big news: ROM: GoldenAge—the hottest upcoming blockchain strategy game—has just smashed through half a million pre-registrations on WEMIX PLAY! Yes, over 500,000 pre-registrations! Pre-register now and …

Upstream Bio Announces First Patient Dosed in Phase 2 Clinical Trial of Verekitug in Chronic Obstructive Pulmonary Disease (COPD)
– Global Phase 2 clinical trial, VENTURE, to evaluate the efficacy and safety of verekitug administered every 12 or 24 weeks in moderate-to-severe COPD – – Broadens global development program for verekitug into third indication, strengthening pipeline …

Jade Biosciences to Participate in Two Upcoming Investor Conferences
SAN FRANCISCO and VANCOUVER, British Columbia, July 08, 2025 (GLOBE NEWSWIRE) -- Jade Biosciences, Inc. (“Jade”), (Nasdaq: JBIO), a biotechnology company focused on developing best-in-class therapies for autoimmune diseases, today announced its …

Plymouth Industrial REIT Provides Activity Update for Second Quarter 2025
BOSTON, July 08, 2025 (GLOBE NEWSWIRE) -- Plymouth Industrial REIT, Inc. (NYSE: PLYM) (the “Company” or “Plymouth”) provided an activity update for the second quarter of 2025. The Company also announced details for its second quarter earnings conference …